Adline Chem Lab Limited has submitted a regulatory filing to BSE Limited regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Thursday, 05th November, 2026.
The primary agenda for the board meeting includes:
- Consideration and approval of Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026
- Review of the Limited Review Report by the Statutory Auditors of the Company
- Any other matter with the permission of the Chair
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct, the trading window for dealing in shares has been closed for all Designated Persons and their immediate relatives. The trading window closure period is from 1st October, 2026 and will remain closed until 48 hours after the announcement/declaration of the Unaudited Financial Results for the quarter and half year ended September 30, 2026.
The disclosure is made pursuant to Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The letter is signed by Vrushank Balkrushna Patel, Managing Director (DIN: 05310613), and digitally signed on 30th October, 2026 at 18:13:36 +05'30'.